Home/Filings/4/0001209191-22-037849
4//SEC Filing

Giles Lisa M. 4

Accession 0001209191-22-037849

CIK 0001828673other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:18 PM ET

Size

5.4 KB

Accession

0001209191-22-037849

Insider Transaction Report

Form 4
Period: 2022-06-15
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-15+41,84141,841 total
    Exercise: $2.39Exp: 2032-06-14Common Stock (41,841 underlying)
Footnotes (1)
  • [F1]100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2023 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date.

Issuer

HCW Biologics Inc.

CIK 0001828673

Entity typeother

Related Parties

1
  • filerCIK 0001568850

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:18 PM ET
Size
5.4 KB